Skip to main content
Top
Published in: Cardiovascular Intervention and Therapeutics 3/2011

01-09-2011 | Original Article

Importance of measuring the fractional flow reserve in patients receiving hemodialysis

Authors: Akiko Matsuo, Hiroshi Fujita, Akira Ueoka, Naoki Maruyama, Yoshiaki Shimoda, Eigo Kishita, Yoshinori Tsubakimoto, Tomohiko Sakatani, Keiji Inoue, Makoto Kitamura, Masato Nishimura

Published in: Cardiovascular Intervention and Therapeutics | Issue 3/2011

Login to get access

Abstract

Angiography is not always an accurate indicator of physiologically significant stenosis. We examined the usefulness of functional evaluation of coronary stenosis severity by determining the fractional flow reserve (FFR) using a pressure wire in patients who received hemodialysis with angiographically intermediate lesions. We recruited 44 patients with intermediate lesions; of these, 22 were undergoing hemodialysis while 22 were not. Quantitative coronary angiography (QCA) was performed to measure the minimal lumen diameter (MLD) and calculate the percent diameter stenosis (%DS). The FFR was calculated as the ratio of the coronary pressure at the distal stenotic site to the mean aortic pressure during maximum hyperemia. In each group, we investigated the relationship between the FFR and %DS and FFR and MLD. The patients in the hemodialysis group were significantly younger and had more calcified and type B2/C lesions than those in the non-dialysis group. Although the FFR was correlated with both %DS (r = 0.71, p < 0.01) and MLD (r = 0.58, p < 0.01) in the non-dialysis group, the FFR was not correlated with either MLD or %DS in the hemodialysis group. In the hemodialysis group, there was a discordance between the QCA- and FFR-based assessments of the severity of coronary stenosis. In patients receiving hemodialysis, both anatomical and functional assessments should be conducted to determine the physiological significance of the stenosis accurately.
Literature
1.
go back to reference Pijls NHJ, De Bruyne B, Peel K, der Voort PV, Bonnir HJRM, Bartunek B, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenosis. N Engl J Med. 1996;334:1703–8.PubMedCrossRef Pijls NHJ, De Bruyne B, Peel K, der Voort PV, Bonnir HJRM, Bartunek B, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenosis. N Engl J Med. 1996;334:1703–8.PubMedCrossRef
2.
go back to reference Takagi A, Tsurumi Y, Ishii Y, Suzuki K, Kawana M, Kasanuki H. Clinical potential of intravascular ultrasound for physiological assessment of coronary stenosis: relationship between quantitative ultrasound tomography and pressure-derived fractional flow reserve. Circulation. 1999;100:250–5.PubMed Takagi A, Tsurumi Y, Ishii Y, Suzuki K, Kawana M, Kasanuki H. Clinical potential of intravascular ultrasound for physiological assessment of coronary stenosis: relationship between quantitative ultrasound tomography and pressure-derived fractional flow reserve. Circulation. 1999;100:250–5.PubMed
3.
go back to reference Jasti V, Ivan E, Yalamanchili V, Wongpraparut N, Leesar MA. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis. Circulation. 2004;110:2831–6.PubMedCrossRef Jasti V, Ivan E, Yalamanchili V, Wongpraparut N, Leesar MA. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis. Circulation. 2004;110:2831–6.PubMedCrossRef
4.
go back to reference Kern MJ, Lerman A, Bech J-W, Bruyne BD, Eeckhout E, Fearon WF, Meuwissen M, Piek JJ, Pijls NHJ, Siebes M, Spaan JAE, et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation. 2006;114:1321–41.PubMedCrossRef Kern MJ, Lerman A, Bech J-W, Bruyne BD, Eeckhout E, Fearon WF, Meuwissen M, Piek JJ, Pijls NHJ, Siebes M, Spaan JAE, et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation. 2006;114:1321–41.PubMedCrossRef
5.
go back to reference Maryland B. US renal data system 2003 annual data report: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2003. Maryland B. US renal data system 2003 annual data report: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2003.
6.
go back to reference Banerjee D, Ma JZ, Collins AJ, Collins AJ, Herzog CA. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol. 2007;2:1186–90.PubMedCrossRef Banerjee D, Ma JZ, Collins AJ, Collins AJ, Herzog CA. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol. 2007;2:1186–90.PubMedCrossRef
7.
go back to reference Yasuda K, Kasuga H, Aoyama T, Takahashi H, Toriyama T, Kawade Y, et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol. 2003;17:2322–32.CrossRef Yasuda K, Kasuga H, Aoyama T, Takahashi H, Toriyama T, Kawade Y, et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol. 2003;17:2322–32.CrossRef
8.
go back to reference Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ, et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol. 2003;14:2373–80.PubMedCrossRef Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ, et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol. 2003;14:2373–80.PubMedCrossRef
9.
go back to reference Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting and coronary artery bypass surgery and impact of diabetes. Circulation. 2002;106:2207–21.PubMedCrossRef Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting and coronary artery bypass surgery and impact of diabetes. Circulation. 2002;106:2207–21.PubMedCrossRef
10.
go back to reference Salah-Eddine H, William WC, Wolfram RM, Kuchulakanti PK, Xue Z, Natalie G, et al. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J invasive cardiol. 2006;18:273–7. Salah-Eddine H, William WC, Wolfram RM, Kuchulakanti PK, Xue Z, Natalie G, et al. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J invasive cardiol. 2006;18:273–7.
11.
go back to reference Wilson RF, White CW. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation. 1986;73:444–51.PubMedCrossRef Wilson RF, White CW. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation. 1986;73:444–51.PubMedCrossRef
12.
go back to reference Courtis J, Rodes-Cabau J, Larose E, Dery JP, Nguyen CM, Proulx G, et al. Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements. Catheter Cardiovasc Interv. 2008;71:541–8.PubMedCrossRef Courtis J, Rodes-Cabau J, Larose E, Dery JP, Nguyen CM, Proulx G, et al. Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements. Catheter Cardiovasc Interv. 2008;71:541–8.PubMedCrossRef
13.
go back to reference Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, Van’t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213–24.PubMedCrossRef Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, Van’t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213–24.PubMedCrossRef
14.
go back to reference White CW, Wright CB, Doty DB, Hiratzav LF, Eastham CL, Harrison DG, Marcus ML. Does visual interpretation of the coronary arteriogram predict the physiological importance of a coronary stenosis? N Engl J Med. 1984;310:819–24.PubMedCrossRef White CW, Wright CB, Doty DB, Hiratzav LF, Eastham CL, Harrison DG, Marcus ML. Does visual interpretation of the coronary arteriogram predict the physiological importance of a coronary stenosis? N Engl J Med. 1984;310:819–24.PubMedCrossRef
15.
go back to reference Vogel RA. Assessing stenosis significance by coronary angiography: are the best variables good enough? J Am Coll Cardiol. 1988;12:692–3.PubMed Vogel RA. Assessing stenosis significance by coronary angiography: are the best variables good enough? J Am Coll Cardiol. 1988;12:692–3.PubMed
16.
go back to reference De Bruyne B, Hersbach F, Pijls NHJ, Bartunek J, Bech JW, Heyndrickx GR, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but “Normal” coronary angiography. Circulation. 2001;104:2401–4.PubMedCrossRef De Bruyne B, Hersbach F, Pijls NHJ, Bartunek J, Bech JW, Heyndrickx GR, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but “Normal” coronary angiography. Circulation. 2001;104:2401–4.PubMedCrossRef
17.
go back to reference Hirota M, Iwasaki K, Yamamoto K, Kusachi S, Hina K, Hirohata S, et al. Coronary pressure measurement to identify the lesion requiring percutaneous coronary intervention in equivocal tandem lesions. Coron Artery Dis. 2006;7:181–6.CrossRef Hirota M, Iwasaki K, Yamamoto K, Kusachi S, Hina K, Hirohata S, et al. Coronary pressure measurement to identify the lesion requiring percutaneous coronary intervention in equivocal tandem lesions. Coron Artery Dis. 2006;7:181–6.CrossRef
18.
go back to reference Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant. 2000;15:218–23.PubMedCrossRef Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant. 2000;15:218–23.PubMedCrossRef
19.
go back to reference Charytan DM, Kuntz RE. Risks of coronary artery bypass surgery in dialysis-dependent patients-analysis of the 2001 National Inpatient Sample. Nephrol Dial Transplant. 2007;22:1665–71.PubMedCrossRef Charytan DM, Kuntz RE. Risks of coronary artery bypass surgery in dialysis-dependent patients-analysis of the 2001 National Inpatient Sample. Nephrol Dial Transplant. 2007;22:1665–71.PubMedCrossRef
20.
go back to reference Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol. 2002;13:1918–27.PubMedCrossRef Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol. 2002;13:1918–27.PubMedCrossRef
21.
go back to reference Nishimura M, Tsukamoto K, Hasebe N, Tamaki N, Kikuchi K, Ono T. Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol. 2008;51:139–45.PubMedCrossRef Nishimura M, Tsukamoto K, Hasebe N, Tamaki N, Kikuchi K, Ono T. Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol. 2008;51:139–45.PubMedCrossRef
22.
go back to reference Kunz K, Dimitrov Y, Muller S, Chanre F, Hannedouche T. Ureamic cardiomyopathy. Nephrol Dial Transplant. 1998;13:39–40.PubMedCrossRef Kunz K, Dimitrov Y, Muller S, Chanre F, Hannedouche T. Ureamic cardiomyopathy. Nephrol Dial Transplant. 1998;13:39–40.PubMedCrossRef
23.
go back to reference Claeys MJ, Bosmans JM, Hendrix J, Vrints CJ. Reliability of fractional flow reserve measurements in patients with associated microvascular dysfunction: Importance of flow on translesional pressure gradient. Catheter Cardiovasc Interv. 2001;54:427–34.PubMedCrossRef Claeys MJ, Bosmans JM, Hendrix J, Vrints CJ. Reliability of fractional flow reserve measurements in patients with associated microvascular dysfunction: Importance of flow on translesional pressure gradient. Catheter Cardiovasc Interv. 2001;54:427–34.PubMedCrossRef
24.
go back to reference Meuwissen M, Chamuleau SAJ, Siebes M, Schotborgh CE, Koch KT, de Winter RJ, et al. Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions. Circulation. 2001;103:184–7.PubMed Meuwissen M, Chamuleau SAJ, Siebes M, Schotborgh CE, Koch KT, de Winter RJ, et al. Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions. Circulation. 2001;103:184–7.PubMed
25.
go back to reference Bech GJW, De Bruyne B, Bonnier HJRM, Bartunek J, Wijns W, Peels K, et al. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol. 1998;31:841–7.PubMedCrossRef Bech GJW, De Bruyne B, Bonnier HJRM, Bartunek J, Wijns W, Peels K, et al. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol. 1998;31:841–7.PubMedCrossRef
26.
go back to reference Pijils NHJ, Van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van’t Veer M, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis. J Am Coll Cardiol. 2007;49:2105–11.CrossRef Pijils NHJ, Van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van’t Veer M, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis. J Am Coll Cardiol. 2007;49:2105–11.CrossRef
27.
go back to reference Sasao H, Hotta D, Maeda T, Saito N, Takagi S, Shimamoto K. Comparison of long-term clinical outcome after sirolimus-eluting stent implantation in patients with and without hemodialysis. Int Heart J. 2007;48:689–700.PubMedCrossRef Sasao H, Hotta D, Maeda T, Saito N, Takagi S, Shimamoto K. Comparison of long-term clinical outcome after sirolimus-eluting stent implantation in patients with and without hemodialysis. Int Heart J. 2007;48:689–700.PubMedCrossRef
Metadata
Title
Importance of measuring the fractional flow reserve in patients receiving hemodialysis
Authors
Akiko Matsuo
Hiroshi Fujita
Akira Ueoka
Naoki Maruyama
Yoshiaki Shimoda
Eigo Kishita
Yoshinori Tsubakimoto
Tomohiko Sakatani
Keiji Inoue
Makoto Kitamura
Masato Nishimura
Publication date
01-09-2011
Publisher
Springer Japan
Published in
Cardiovascular Intervention and Therapeutics / Issue 3/2011
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-011-0061-4

Other articles of this Issue 3/2011

Cardiovascular Intervention and Therapeutics 3/2011 Go to the issue